Table of Content

1 INTRODUCTION (Page No. - 19)
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
           1.6.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY (Page No. - 24)
    2.1 RESEARCH METHODOLOGY 
    2.2 SECONDARY & PRIMARY RESEARCH METHODOLOGY 
           2.2.1 SECONDARY RESEARCH
           2.2.2 PRIMARY RESEARCH
    2.3 MARKET ESTIMATION METHODOLOGY 
           2.3.1 PRODUCT-BASED MARKET ESTIMATION
           2.3.2 PRIMARY RESEARCH VALIDATION
    2.4 DATA TRIANGULATION 
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
    2.7 RECESSION IMPACT  
3 EXECUTIVE SUMMARY (Page No. - 32)
4 PREMIUM INSIGHTS (Page No. - 37)
    4.1 ROBOTIC RADIOTHERAPY  MARKET OVERVIEW 
    4.2 EUROPE: ROBOTIC RADIOTHERAPY MARKET,  BY SAMPLING METHOD AND REGION 
    4.3 ROBOTIC RADIOTHERAPY MARKET, BY POLLUTANT 
    4.4 GEOGRAPHIC SNAPSHOT OF THE ROBOTIC RADIOTHERAPY MARKET 
5 MARKET OVERVIEW (Page No. - 41)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 KEY MARKET DRIVERS
           5.2.2 KEY MARKET RESTRAINTS
           5.2.3 KEY MARKET OPPORTUNITIES
           5.2.4 KEY MARKET CHALLENGES
    5.3 PORTER’S FIVE FORCES ANALYSIS 
           5.3.1 OVERVIEW
           5.3.2 THREAT OF NEW ENTRANTS
           5.3.3 THREAT OF SUBSTITUTES
           5.3.4 BARGAINING POWER OF SUPPLIERS
           5.3.5 BARGAINING POWER OF BUYERS
           5.3.6 DEGREE OF COMPETITION
    5.4 REGULATORY SCENARIO 
           5.4.1 WHO
           5.4.2 US
           5.4.3 EUROPEAN UNION
                    5.4.3.1 Existing air quality legislation in the EU
                    5.4.3.2 The EU and international air pollution policies
           5.4.4 OTHERS
                    5.4.4.1 India
           5.4.5 CHINA
    5.5 ECOSYSTEM COVERAGE 
    5.6 VALUE CHAIN ANALYSIS 
    5.7 PRICING ANALYSIS 
    5.8 PATENT ANALYSIS 
    5.9 TRADE DATA ANALYSIS 
    5.10 TECHNOLOGY ANALYSIS 
    5.11 CASE STUDY ANALYSIS 
    5.12 KEY CONFERENCES AND EVENTS (2022-2024) 
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.13.2 BUYING CRITERIA
6 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT (Page No. - 64)
    6.1 INTRODUCTION 
    6.2 RADIOTHERAPY SYSTEM 
    6.3 SOFTWARE 
    6.4 3D CAMERA 
    6.5 OTHERS 
7 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY (Page No. - 71)
    7.1 INTRODUCTION 
    7.2 LINEAR ACCELATORS 
           7.2.1 CONVENTIONAL LINEAR ACCELATORS
           7.2.2 MRI – LINEAR ACCELATORS
    7.3 STERIOTACTIC RADIATION THERAPY SYSTEMS 
           7.3.1 CYBERKNIFE
           7.3.1 GAMMA KNIFE
    7.4 PARTICLE THERAPY 
           7.4.1 PROTON BEAM THERAPY
           7.4.1 HEAVY ION BEAM THERAPY
8 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION (Page No. - 85)
    8.1 INTRODUCTION 
    8.2 PROSTATE CANCER 
    8.3 BREAST CANCER 
    8.4 LUNG CANCER 
    8.5 HEAD & NECK CANCER 
    8.6 COLORECTAL CANCER 
    8.7 OTHER CANCERS 
9 ROBOTIC RADIOTHERAPY MARKET, BY END USER (Page No. - 112)
    9.1 INTRODUCTION 
    9.2 HOSPITALS 
    9.3 INDEPENDENT RADIOTHERAPY CENTERS 
10 ROBOTIC RADIOTHERAPY MARKET, BY REGION (Page No. - 123)
     10.1 INTRODUCTION 
     10.2 NORTH AMERICA 
             10.2.1 RECESSION IMPACT
             10.2.1 US
             10.2.2 CANADA
     10.3 EUROPE 
             10.3.1 RECESSION IMPACT
             10.3.1 GERMANY
             10.3.2 UK
             10.3.3 FRANCE
             10.3.4 ITALY
             10.3.5 SPAIN
             10.3.6 REST OF EUROPE
     10.4 ASIA PACIFIC 
             10.4.1 RECESSION IMPACT
             10.4.1 JAPAN
             10.4.2 CHINA
             10.4.3 INDIA
             10.4.4 AUSTRALIA
             10.4.5 SOUTH KOREA
             10.4.6 REST OF ASIA PACIFIC
     10.5 REST OF WORLD 
             10.5.1 RECESSION IMPACT
11 COMPETITIVE LANDSCAPE (Page No. - 179)
     11.1 OVERVIEW 
     11.2 MARKET SHARE ANALYSIS: AUTOMATED RADIATION THERAPY SYSTEM MARKET, BY KEY PLAYER (2022) 
     11.3 COMPANY EVALUATION QUADRANT 
             11.3.1 TERMINOLOGY/NOMENCLATURE
                        11.3.1.1 Stars
                        11.3.1.2 Emerging leaders
                        11.3.1.3 Pervasive players
                        11.3.1.4 Participants
     11.4 COMPETITIVE SCENARIO (2019–2022) 
12 COMPANY PROFILES (Page No. - 187)
     12.1 KEY PLAYERS 
             12.1.1 VARIAN MEDICAL SYSTEMS, INC.  
             12.1.2 ELEKTA
             12.1.3 ACCURAY INCORPORATED
             12.1.4 VIEWRAY TECHNOLOGIES, INC.
             12.1.5 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
             12.1.6 IBA PROTON THERAPY
             12.1.7 MEVION MEDICAL SYSTEMS
             12.1.8 HITACHI, LTD. 
             12.1.9 SUMITOMO HEAVY INDUSTRIES, LTD.
             12.1.10 PROTOM INTERNATIONAL
             12.1.11 OPTIVUS PROTON THERAPY, INC.
             12.1.12 P-CURE.
             12.1.13 PROVISION HEALTHCARE, LLC
             12.1.14 STANDARD IMAGING, INC. .
             12.1.15 BRAINLAB AG
             12.1.14  C-RAD
             12.1.15 RAYSEARCH LABORATORIES.
             12.1.16 DOSISOFT SA. 
             12.1.17 MIM SOFTWARE, INC. 
             12.1.18 SUN NUCLEAR CORPORATION
             12.1.19 SCANDIDOS AB
             12.1.20 VISION RT
             12.1.21 CIVCO RADIOTHERAPY
             12.1.22 LAP GMBH LASER APPLIKATIONEN
             12.1.23 MVISION AI
             12.1.24 LINATECH, INC..
13 APPENDIX (Page No. - 249)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 AVAILABLE CUSTOMIZATIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS